CA Stock MarketDetailed Quotes
RP RepliCel Life Sciences Inc
- 0.015
- 0.0000.00%
15min DelayPost Market Nov 5 16:00 ET
975.02KMarket Cap-750P/E (TTM)
0.000High0.000Low901Volume0.010Open0.015Pre Close9.01Turnover0.10052wk High0.00%Turnover Ratio65.00MShares0.01052wk Low-0.02EPS TTM475.47KFloat Cap9.900Historical HighLossP/E (Static)31.70MShs Float0.010Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-0.15P/B1Lot Size--Div YieldTTM
RepliCel Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.81%-200.29K | 2.55%-430.01K | -233.45%-1.12M | 43.93%-1.41M | 54.04%-240.64K | -131.29%-391.29K | 83.68%-441.26K | 37.30%-336.26K | -228.52%-2.51M | -332.10%-523.55K |
| Net income from continuing operations | 26.63%-818.6K | 49.76%-558.15K | -22.36%-963.37K | 81.75%-743.23K | 372.61%2.27M | -33.48%-1.12M | -5.90%-1.11M | 41.91%-787.33K | -157.76%-4.07M | -227.39%-832.99K |
| Operating gains losses | 17.64%114.42K | -106.08%-5.68K | 145.82%220.18K | -40.79%587.11K | 271.22%306.96K | -90.91%97.27K | 108.82%93.32K | -90.01%89.57K | 306.76%991.56K | 143.03%82.69K |
| Depreciation and amortization | --0 | 425.24%1.1K | -53.11%98 | -26.92%839 | -26.83%210 | -75.61%210 | 153.30%210 | -46.95%209 | -27.06%1.15K | 48.70%287 |
| Remuneration paid in stock | 216.89%234.6K | -88.49%14.98K | -87.70%14.98K | -85.36%69.06K | -85.10%17.88K | -157.06%-200.7K | --130.13K | --121.75K | 13,787.43%471.76K | --120K |
| Other non cashItems | -61.13%285.82K | -67.63%146.63K | -40.42%158.57K | -479.45%-1.59M | -1,231.43%-3.05M | 139.17%735.31K | -78.50%453.04K | 434.42%266.17K | 219.91%419.23K | 342.78%269.15K |
| Change In working capital | -117.89%-16.52K | -317.94%-28.89K | -1,971.64%-551.74K | 182.52%267.55K | 228.33%208.77K | -94.58%92.32K | 99.63%-6.91K | -1,879.09%-26.63K | -135.40%-324.24K | -129.23%-162.69K |
| -Change in receivables | -4.49%-5.03K | -67.58%-13.25K | 33.85%-3.3K | -980.81%-20.93K | 29.45%-3.22K | -134.37%-4.81K | -893.22%-7.91K | 20.22%-5K | 120.27%2.38K | 8.95%-4.56K |
| -Change in prepaid assets | -114.05%-39.92K | 312.48%119.64K | 39.04%-16.92K | -30.42%-29.87K | 42.56%-12.48K | -108.11%-18.65K | 113.56%29.01K | -59.96%-27.75K | -139.35%-22.9K | 53.23%-21.73K |
| -Change in payables and accrued expense | -75.45%28.43K | -382.95%-135.28K | -8,802.05%-531.52K | 206.74%321.16K | 270.14%227.29K | -92.07%115.78K | 98.31%-28.01K | -75.67%6.11K | -135.06%-300.89K | -122.38%-133.59K |
| -Change in other working capital | ---- | ---- | ---- | 0.04%-2.82K | ---- | ---- | ---- | ---- | -125.01%-2.82K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.81%-200.29K | 2.55%-430.01K | -233.45%-1.12M | 43.93%-1.41M | 54.04%-240.64K | -194.48%-391.29K | 76.38%-441.26K | 37.30%-336.26K | -228.52%-2.51M | -332.10%-523.55K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | ||||||||
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -107.39%-42.49K | 625.94%1.4M | -40.71%1.6M | 374.13%575.61K | -88.91%258.6K | 177.99%574.74K | -80.45%192.34K | 253.43%2.7M | 150.77%121.4K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | -2,528.37%-1.63M |
| Net common stock issuance | --0 | -105.60%-42.49K | --1.4M | --1.6M | 163.37%841.97K | -100.00%2 | 1,179.70%759.32K | --0 | --0 | -417.82%-1.33M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.8K | ---- |
| Net other financing activities | -100.00%-1 | ---- | ---- | ---- | ---- | --258.6K | ---184.58K | -77.00%192.34K | --2.7M | --3.39M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.00%-1 | -107.39%-42.49K | 625.94%1.4M | -40.71%1.6M | 33.01%575.61K | -87.20%258.6K | 177.99%574.74K | -80.45%192.34K | 253.43%2.7M | 280.99%432.77K |
| Net cash flow | ||||||||||
| Beginning cash position | 2.26%215.52K | 780.11%680.01K | 86.73%413.03K | 543.68%221.19K | -74.98%78.06K | 30.83%210.75K | -83.97%77.27K | 543.68%221.19K | 43.60%34.36K | 548.31%311.97K |
| Current changes in cash | -50.94%-200.29K | -447.98%-464.5K | 285.51%266.99K | 2.68%191.84K | 470.09%334.97K | -194.66%-132.69K | 143.01%133.49K | -132.16%-143.92K | 1,690.71%186.83K | -557.82%-90.51K |
| End cash Position | -80.49%15.23K | 2.26%215.52K | 780.11%680.01K | 86.73%413.03K | 86.73%413.03K | -74.98%78.06K | 30.83%210.75K | -83.97%77.27K | 543.68%221.19K | 543.68%221.19K |
| Free cash from | 48.81%-200.29K | 2.55%-430.01K | -233.45%-1.12M | 43.93%-1.41M | 54.04%-240.64K | -194.48%-391.29K | 76.38%-441.26K | 37.30%-336.26K | -228.52%-2.51M | -332.10%-523.55K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data